CHINA NT PHARMA GROUP COMPANY LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.028 HKD | +7.69% |
|
+21.74% | -49.09% |
ETFs positioned on China NT Pharma Group Company Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 114 M€ | +5.12% | - |
China NT Pharma Group Company Ltd is an investment holding company principally engaged in the research and development, production and sales of pharmaceutical products. The Company mainly provides development, distribution and agency services for sales of proprietary pharmaceutical products. The Company operates its bone health digital medicine platform by providing customized health package including bone health products, equipment and rehabilitation products. In addition, the Company engages in the investment in drugs and pharmaceutical companiesâ equity as well as provision of marketing and promotion services to suppliers.
Sector
Pharmaceuticals
Calendar
27/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -49.09% | 8.8M | |
| +51.99% | 798B | |
| -5.72% | 356B | |
| +18.94% | 328B | |
| +11.07% | 304B | |
| +16.96% | 244B | |
| +2.25% | 227B | |
| +11.15% | 216B | |
| +7.59% | 166B | |
| -3.65% | 157B |
- Stock Market
- Equities
- 1011 Stock
- Funds and ETFs China NT Pharma Group Company Limited
